Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1250 East Marshall Street
Internal Medicine
Richmond, VA 23298Phone+1 804-828-9690Fax+1 804-828-5566
Education & Training
- University of Alabama Medical CenterInternship, Internal Medicine, 1981 - 1982
- University of Alabama School of MedicineClass of 1981
Certifications & Licensure
- VA State Medical License 1991 - 2024
- TN State Medical License 1983 - 1997
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Pain in Sickle Cell Epidemiologic Study Start of enrollment: 2001 Oct 01
- Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators Start of enrollment: 2012 Oct 01
- A Study of SHP655 (rADAMTS13) in Sickle Cell Disease Start of enrollment: 2019 Oct 21
Roles: Principal Investigator
Publications & Presentations
PubMed
- 337 citationsThe risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-upMartin H. Steinberg, William F. McCarthy, Oswaldo Castro, Samir K. Ballas, F. Danny Armstrong
American Journal of Hematology. 2010-06-01 - 155 citationsA Phase 3 Trial of l-Glutamine in Sickle Cell Disease.Yutaka Niihara, Scott T Miller, Julie Kanter, Sophie Lanzkron, Wally R Smith
The New England Journal of Medicine. 2018-07-19 - 5 citationsSatisfaction and access to care for adults and adolescents with sickle cell disease: ASCQ-Me quality of care and the SHIP-HU study.India Sisler, Donna K McClish, Cecelia Valrie, Anthony Villella, Wally R Smith
Pediatric Blood & Cancer. 2022-12-01
Journal Articles
- Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two InstrumentsWally R Smith, Sebastian T Tong, Journal of The American Board of Family Medicine
- A Phase 3 Trial of L-glutamine in Sickle Cell DiseaseRita Bellevue, Joseph L Lasky, Elliott P Vichinsky, Lewis L Hsu, Sharada Sarnaik, Lynne D Neumayr, Yutaka Niihara, Sophie Lanzkron, Ifeyinwa Osunkwo, Lance Sieger, Edu..., The New England Journal of Medicine
Abstracts/Posters
- Development and Validation of a Functional Status-Based Pain Assessment ToolWally R Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Severity Classification for Sickle Cell Disease: A RAND/UCLA Modified Delphi PanelWally R Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Crizanlizumab Versus Placebo, with or without Hydroxyurea/Hydroxycarbamide, in Adolescent and Adult Patients with Sickle Cell Disease and Vaso-Occlusive Crises: A Rand...Wally R Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- The Effect of Patient Navigators on Laboratory Parameters of Hydroxyurea Adherence in Sickle Cell Anemia: The SHIP-HU Study61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Case Management Featuring Community Health Workers Reduces Inpatient Health Care Utilization in Adults with Sickle Cell Disease61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- The Effect of Patient Navigators on Laboratory Parameters of Hydroxyurea Adherence in Sickle Cell Anemia: The SHIP-HU Study61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Join now to see all
Press Mentions
- Promising New Sickle Cell Therapy Trialed at Children's Hospital of Richmond at VCU and VCU Medical CenterDecember 18th, 2023
- SGLT2 Inhibitors Reduces Hospitalization for Heart Failure Regardless of Presence of DiabetesApril 11th, 2022
- Hydroxyurea-Based Treatment for Sickle Cell Anemia Previously Available for Pediatric Patients Now Approved for Use in AdultsFebruary 16th, 2022
- Join now to see all
Grant Support
- Virginia Basic And Translational Research ProgramNational Heart, Lung, And Blood Institute2009–2011
- Career Development For A Sickle Cell ScholarNational Heart, Lung, And Blood Institute2008–2011
- Administrative CoreNational Heart, Lung, And Blood Institute2008–2011
- Morphine Pharmacokinetics And Pharmacodynamics In Sickle Cell DiseaseNational Center For Research Resources2010
- Comparative Effectiveness Of Virginia Coordinated Care Versus The Traditional SAFAgency For Healthcare Research And Quality2010
- Virginia Comprehensive Sickle Cell Center-Center: Basic &Translational ResearchNational Heart, Lung, And Blood Institute2008
- Virginia Commonwealth University Sickle Cell Disease Clinical NetworkNational Heart, Lung, And Blood Institute2007–2008
- Virginia Commonwealth University Sickle Cell DiseaseNational Heart, Lung, And Blood Institute2006
- Multi-Center Study Of Hydroxyurea In Sickle Cell Anemia (MSH) Patients FollowNational Center For Research Resources2006
- Pain In Sickle Cell Epidemiology Study (PISCES)National Center For Research Resources2004
- Pain In Sickle Cell Epidemiologic StudyNational Heart, Lung, And Blood Institute2001–2003
- Multicenter Study Of Hydroxyurea 5 Years Follow-Up StudyNational Center For Research Resources1998–2001
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: